Augmented Fibroblast Growth Factor-23 Secretion in Bone Locally Contributes to Impaired Bone Mineralization in Chronic Kidney Disease in Mice

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2018.00311
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Fibroblast Growth Factor 23 and Cardiovascular Disease in Patients With Chronic Kidney Disease

Renal Replacement Therapy
2018English

Fibroblast Growth Factor 23 Is Upregulated in the Kidney in a Chronic Kidney Disease Rat Model

PLoS ONE
Multidisciplinary
2018English

Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease

JAMA - Journal of the American Medical Association
Medicine
2011English

Regulation of Fibroblast Growth Factor 23 ( FGF 23) in Health and Disease

FEBS Letters
GeneticsCell BiologyMolecular BiologyBiochemistryStructural BiologyBiophysics
2019English

Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE

Circulation
Cardiovascular MedicinePhysiologyCardiology
2015English

Nuclear Fibroblast Growth Factor 2 (FGF2) Isoforms Inhibit Bone Marrow Stromal Cell Mineralization Through FGF23/FGFR/MAPK in Vitro

Journal of Bone and Mineral Research
EndocrinologyOrthopedicsSports MedicineMetabolismDiabetes
2012English

Fibroblast Growth Factor 23 and Inflammation in CKD

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2012English

Effects of Acute Kidney Injury and Chronic Hypoxemia on Fibroblast Growth Factor 23 Levels in Pediatric Cardiac Surgery Patients

Pediatric Nephrology
Child HealthPediatricsPerinatologyNephrology
2015English

Fibroblast Growth Factor 23: Friend or Foe in Uremia?

Journal of Clinical Investigation
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy